DRUGS MADE IN AMERICA ACQUIS

關鍵數據

公司概況

板塊

--

行業

N/A

子行業

--

總部

--

國家

US

上市日期

2025-09-25

財年截止

--

流通股數

63.7M

CIK

--

官方網址

--

Drugs Made In America Acquisition II Corp. (DMIIU) is a special purpose acquisition company (SPAC) focused on merging with transformative companies in the pharmaceutical and biotechnology sectors, with a specific emphasis on enhancing domestic drug manufacturing. By investing in businesses that showcase innovative technologies and solid operational strategies, DMIIU aims to tackle significant challenges within the healthcare landscape. The company's mission is to generate substantial shareholder value while playing a vital role in the advancement of the American healthcare system, driving efficiency and effectiveness in domestic drug production. Through its strategic investment paradigm, DMIIU is positioned to lead the charge in revolutionizing the pharmaceutical manufacturing space.

財務指標

--

常見問題